Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Alexander Noor Shoushtari

Memorial Sloan Kettering Cancer Center

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (19)

Joseph J. Sacco

Clinical Senior Lecturer

University of Liverpool

UNITED KINGDOM

View details

Konstantinos Linos

Associate Attending

Memorial Sloan Kettering Cancer Center

UNITED STATES

View details

Daniel J. Powell

Associate Professor

University of Pennsylvania

UNITED STATES

View details

Taha Merghoub

Deputy Director, Meyer Cancer Center

Weill Cornell Medicine

UNITED STATES

View details

Bartosz Chmielowski

Ronald Reagan UCLA Medical Center

UNITED STATES

View details

Hooman Yarmohammadi

Professor of Radiology

Memorial Sloan Kettering Cancer Center

UNITED STATES

View details

Dan Gombos

Professor and Section Chief

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Alexandra Ikeguchi

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Zelia Correa

Professor of Ophthalmology, Co-Director Ocular Oncology Program

University of Miami Health System Bascom Palmer Eye Institute

UNITED STATES

View details

Paul Nathan

University College London

UNITED KINGDOM

View details

Bin Zheng

Professor

Cedars-Sinai Medical Center

UNITED STATES

View details

J. William Harbour

Professor and Chair

University of Texas Southwestern Medical Center

UNITED STATES

View details

Jonathan S. Zager

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES

View details

Arun Singh

Professor

Cleveland Clinic

UNITED STATES

View details

Jedd Wolchok

Director

Weill Cornell Medicine

UNITED STATES

View details

Piotr Rutkowski

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

View details

Paul Lorigan

The University of Manchester

UNITED KINGDOM

View details

Shailender Bhatia

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Sanjay Chandrasekaran

Assistant Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alexander Noor Shoushtari

Research Interests

Make your next move.

Explore related searches

Articles (20)

Comprehensive Genomic Characterization of Primary Dermal Melanoma: Delineating it from Metastatic Melanoma with Unknown Primary

Infections in Patients with Solid Tumors Undergoing Adoptive Cellular Therapy

Outpatient Treatment-Related Toxicity After Hospital Discharge Among Patients Receiving Lifileucel for Advanced Melanoma

T-Cell Clonal Expansion in Peripheral Blood Following Interventional Radiology Procedures for Metastatic Liver Cancer

Tumor-Infiltrating Lymphocyte Therapy for Melanoma and Other Solid Tumors: Looking Back, Yet Moving Forward

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus

Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients

Bridging the Gap: Incorporating Lifileucel Into Management of Advanced PD-1 Blockade Resistant Melanomas

Correction: Shoushtari et al. A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma. Cancers 2021, 13, 5504

Immunotherapy and transarterial embolization in patients with metastatic melanoma: a retrospective cohort study

Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma

Clinical benefit with tebentafusp in a patient with GNAQ mutant metastatic blue nevus-associated melanoma

Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab

Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study

Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma

Phase Ib trial of phenformin in patients with V600-mutated melanoma receiving dabrafenib and trametinib

Determinants of overall survival in patients with metastatic uveal melanoma

Beyond the 5‐year milestone: Long‐term survivorship of melanoma patients treated off‐trial with anti‐PD‐1

Correction to: Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival

Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival

Collaborators (19)

Joseph J. Sacco

Konstantinos Linos

Daniel J. Powell

Taha Merghoub

Bartosz Chmielowski

Hooman Yarmohammadi

Dan Gombos

Alexandra Ikeguchi

Zelia Correa

Paul Nathan

Bin Zheng

J. William Harbour

Jonathan S. Zager

Arun Singh

Jedd Wolchok

Piotr Rutkowski

Paul Lorigan

Shailender Bhatia

Sanjay Chandrasekaran

Make your next move.